Univar Solutions expands pharmaceutical products portfolio with Ashland

The agreement will expand Univar Solutions helping customers with drug delivery in Brazil and Mexico

0
12
Univar
Univar Solutions expands pharmaceutical products portfolio through new distribution agreement with Ashland. Photo Univar

Univar Solutions, a chemical and ingredient distributor and provider of value-added services, today expanded its specialty ingredient portfolio in Mexico and Brazil through a new distribution agreement with Ashland, a focused additives and specialty ingredients company. The agreement combines the strengths and offerings of two sustainability-focused and innovation-driven organizations and will benefit formulators and manufacturers focused on delivering science-based pharmaceutical solutions in Latin America and across the globe.

“Univar Solutions proudly serves pharmaceutical manufacturers and formulators through our relationships with premier suppliers like Ashland, offering the ingredients and solutions our customers are seeking for their high quality and high performing products, globally,” said Jorge Buckup, president of Latin America for Univar Solutions. “Together with Ashland, we’re better able to help customers formulate next-generation products, work to improve time to market and achieve a sustainability advantage using more environmentally conscious ingredients and innovations. We’re proud to team up with a supplier who is also passionate about working at the intersection of science and technology to deliver products that help keep communities healthy and safe.”

Printpack Showdaily

Under the agreement, Univar customers in Brazil and Mexico will have access to Ashland’s binders and disintegrants for solid dosage forms, matrix formers for modulated release drugs and coatings for regular and modulated release solid dosage forms. Pharmaceutical ingredient customers are supported by Univar Solutions’ global Solution Centers scientists, who help solve formulation challenges, address changing regulatory requirements, innovate to meet market trends and help customers work toward sustainability and other environmental, social and governance (ESG) goals.

“Ashland’s specialty ingredients are a perfect complement and addition to our existing portfolio and with it, we look forward to offering an even more expansive range of excipients to customers in Brazil and Mexico,” said James Peterson, vice-president, global pharmaceutical ingredients for Univar. “Partnering with Ashland will help further our approach to manufacturers and formulators as we work together to meet the ever-changing pharmaceutical market demands in Latin America, backed by the technical expertise from our global network of Solution Centers.”

“As a global leader in pharmaceutical oral solid dose (OSD) excipients, Ashland is innovating for safe, easy-care, patient-centric formulations and we will continue to grow by building out our pipeline with these innovations and new sales opportunities,” said Alejandra Alvarez, strategic global marketing and business development of Latin America for Ashland. “We are excited for our customers that will be supported by Univar Solutions as they help us address evolving global pharmaceutical needs coinciding with the growing pharmaceutical industry in Brazil and Mexico.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here